Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Blom

Showing results (361-370 of 366) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 366 results.
European Heart Journal|May 31, 2019
Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrestChristian van der Werf, Krystien V Lieve, J Martijn Bos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 11, 2021
Rare variants in KDR, encoding VEGF Receptor 2, are associated with tetralogy of FallotDoris Škorić-Milosavljević, Najim Lahrouchi, Fernanda M Bosada, et al.
Heart Rhythm|April 8, 2024
An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardiaAvani Lamba, Thomas M Roston, Puck J Peltenburg, et al.
Circulation|December 7, 2021
An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular TachycardiaPuck J Peltenburg, Dania Kallas, Johan M Bos, et al.
European Heart Journal|July 31, 2018
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroupsAlban-Elouen Baruteau, Florence Kyndt, Elijah R Behr, et al.
European Heart Journal|December 19, 2025
Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratificationKrystien V Lieve, Christian van der Werf, Dania Kallas, et al.
Pageof 37

Showing results (361-370 of 366) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 366 results.
European Heart Journal|May 31, 2019
Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrestChristian van der Werf, Krystien V Lieve, J Martijn Bos, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 11, 2021
Rare variants in KDR, encoding VEGF Receptor 2, are associated with tetralogy of FallotDoris Škorić-Milosavljević, Najim Lahrouchi, Fernanda M Bosada, et al.
Heart Rhythm|April 8, 2024
An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardiaAvani Lamba, Thomas M Roston, Puck J Peltenburg, et al.
Circulation|December 7, 2021
An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular TachycardiaPuck J Peltenburg, Dania Kallas, Johan M Bos, et al.
European Heart Journal|July 31, 2018
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroupsAlban-Elouen Baruteau, Florence Kyndt, Elijah R Behr, et al.
European Heart Journal|December 19, 2025
Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratificationKrystien V Lieve, Christian van der Werf, Dania Kallas, et al.
Pageof 37